<html>
<head>PUBMED IDs for EYA3</head>
<body bgcolor='#C5F0F2'><h1>EYA3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15257456/'>CHX10 mutations cause non-syndromic microphthalmia/ anophthalmia in Arab and Jewish kindreds.</a> July 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/20418914/'>The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells.</a> July 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22545090/'>The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.</a> August 28  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22545089/'>Novel regulatory mechanisms for generation of the soluble leptin receptor: implications for leptin action.</a> August 28  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22545084/'>Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.</a> August 28  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22723308/'>EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.</a> April 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24441146/'>t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.</a> April 14  2014<br></body></html>
